- Home
- PFLT vs LXEO Comparison
PFLT vs LXEO Comparison
Compare PFLT & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PFLT | LXEO |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.9M | 731.3M |
| IPO Year | 2010 | 2023 |
Fundamental Metrics
Financial Performance| Metric | PFLT | LXEO |
|---|---|---|
| Price | $8.19 | $7.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $10.67 | ★ $18.60 |
| AVG Volume (30 Days) | ★ 1.3M | 710.0K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 14.56% | N/A |
| EPS Growth | N/A | ★ 75.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $654,000.00 |
| Revenue This Year | $11.65 | N/A |
| Revenue Next Year | $0.49 | N/A |
| P/E Ratio | $24.14 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.18 | $1.45 |
| 52 Week High | $11.42 | $10.99 |
Technical Indicators
Market Signals| Indicator | PFLT | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 29.51 | 50.11 |
| Support Level | N/A | $6.90 |
| Resistance Level | $9.46 | $7.40 |
| Average True Range (ATR) | 0.22 | 0.39 |
| MACD | -0.06 | 0.13 |
| Stochastic Oscillator | 1.52 | 86.52 |
Price Performance
Historical ComparisonAbout PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate both current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generates revenue in the form of interest income on the debt securities and dividends.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.